Journal Title：Journal Of Tissue Engineering And Regenerative Medicine

Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs.

The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.

《組織工程與再生醫(yī)學雜志》發(fā)表快速而嚴格的同行評審研究論文、評論、臨床病例報告、觀點和簡短通訊，主題涉及結合干細胞或祖細胞、生物材料和支架、生長因子和其他生物活性劑及其各自構造的治療方法的開發(fā)。所有論文都應涉及對組織和器官再生或修復的新臨床方法的開發(fā)有直接或潛在影響的研究。

該雜志是多學科的，涵蓋了生命科學和工程原理的結合，以推進醫(yī)學和臨床策略。該雜志側重于使用細胞、材料和生化/機械因素來開發(fā)恢復、維持或改善組織或器官功能的生物功能替代品。該雜志發(fā)表關于任何組織或器官的研究，涵蓋該領域的所有關鍵方面，包括新生物材料的開發(fā)和支架的加工；使用不同類型的細胞（主要是干細胞和祖細胞）及其在特定生物反應器中的培養(yǎng)；相關動物模型的研究；以及在嚴格的監(jiān)管和道德框架下對人類患者進行的臨床試驗。描述使用先進方法表征工程組織的稿件也引起了期刊讀者的特別興趣。

Journal Of Tissue Engineering And Regenerative Medicine創(chuàng)刊于2007年，由John Wiley and Sons Ltd出版商出版，收稿方向涵蓋生物 - 工程：生物醫(yī)學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 偏慢,4-8周 ，影響因子指數3.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。